Medical Technology Specialist Joins CD&R Healthcare Team



Nadav Tomerformer senior executive at Johnson & Johnson, serves as operational advisor to CD&R Funds

NEW YORK, May 3, 2022 /PRNewswire/ — Clayton, Dubilier & Rice Announcement Nadav Tomer, a specialist in medical technologies, has been appointed Operating Advisor of the CD&R funds. Mr. Tomer will work with CD&R’s healthcare team to help source new investments and advise fund healthcare companies.

Mr. Tomer has 22 years of experience in leadership roles in the medical technology industry, leading various global franchises at Johnson & Johnson focused on a range of therapeutic areas including diabetes care, spine, cardiology , endovascular, orthopedics and electrophysiology, both in the United States and Europe. Most recently as Global Chairman of Johnson & Johnson’s $1.4 billion A DePuy Synthes Spine franchisee, Mr. Tomer led global strategy, business execution, innovation, portfolio and brand management, as well as the process of recruiting new talent and reforming the company’s culture. organization. This resulted in a tripling of the value of the Spine business pipeline, advancing the company’s portfolio and stabilizing the business from previous market share losses.

“Nadav brings a strong track record of execution and deep experience leading global medical technology companies across a range of therapeutic areas and disciplines,” said CD&R Partner Derek Strum. “We believe it will be very helpful in creating differentiated angles and enhancing our ability to underwrite execution-based, high-conviction investment cases as we seek to expand our medical technology investments.”

“CD&R has a strong reputation for building and growing businesses, particularly in the healthcare space,” Mr. Tomer said. “I look forward to working with CD&R’s talented team of investment and operating professionals and contributing to the continued success of CD&R funds and their portfolio companies in the medical technology industry.”

Currently, Mr. Tomer serves on the board of Augmedics, Agada Medical and Vascular Graft Solutions. He graduated from the Advanced Management program of Harvard Business Schoolholds a bachelor’s degree in medicine from Ben Gurion University of the Negevand an MBA in finance and new ventures from Bar IIan University.

About Clayton, Dubilier & Rice

Clayton, Dubilier & Rice is a private investment firm whose strategy is based on building stronger, more profitable businesses. Since its creation, CD&R has managed the investment of more than $40 billion in more than 100 companies with a total transaction value of more than $175 billion. The Firm has offices at New York and London. For more information, please visit

View original content to download multimedia:

SOURCE Clayton, Dubilier & Rice

Source link


Comments are closed.